Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Anesthesia CO2 Absorbent Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Report Format: PDF+Excel | Report ID: SR112023A5963
Year End
sale
Buy Now
Market Overview:
The global anesthesia CO2 absorbent market size reached US$ 73.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 111.5 Million by 2028, exhibiting a growth rate (CAGR) of 6.3% during 2023-2028.
Anesthesia CO2 absorbent is a specific segment within the anesthesia disposables, which is primarily used to absorb exhaled gases during anesthesia administration. Consisting of strong potassium hydroxide and sodium hydroxide bases that help obtain labile protons from anesthetic molecules to carbon monoxide (CO), these absorbent formulations are instrumental in minimizing anesthetic wastes. The CO2 absorber devices consisting of anesthesia absorbents are incorporated into the ventilatory apparatus of the anesthesia machine between the inspiratory and expiratory limbs of a circle circuit. They function by limiting the flow of fresh gas to closed-circuit conditions and allowing exhaled anesthetic agents to be rebreathed. However, the production of carbon monoxide (CO) can cause health hazards to patients. Certain CO2 absorbents do not contain potassium hydroxide, and sodium hydroxide and consequently do not produce carbon monoxide by reacting with inhaled agents.
Anesthesia CO2 Absorbent Market Trends:
The market is primarily driven by the rising incidences of chronic conditions, such as cardiac disorders, neurological conditions, respiratory diseases, and diabetes. Along with this, the growing geriatric population that is susceptible to developing medical conditions ultimately requiring surgical intervention is providing a significant boost to the market. Besides this, with the rising number of surgeries conducted across numerous healthcare settings, there has been a considerable rise in the demand for anesthesia disposables, thereby contributing to the product adoption across the globe. Various stringent government guidelines and safety parameters regarding the usage of anesthetic drugs and equipment across the healthcare sector are further propelling the product demand. In addition to this, the increasing investments in the research and development (R&D) activities for developing advanced CO2 absorbing formulations and the expanding healthcare expenditure are also providing an impetus to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anesthesia CO2 absorbent market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type and end user.
Breakup by Product:
- Soda Lime
- Medisorb
- Dragersorb
- Amsorb
- Litholyme
- Others
Breakup by Type:
- Premium
- Traditional
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Armstrong Medical Ltd. (Eakin Healthcare Group Ltd), Atrasorb, Drägerwerk AG & Co. KGaA, General Electric Company, Intersurgical Ltd., Löwenstein Medical SE & Co. KG, Micropore Inc., Molecular Products Group plc (Filtration Group Corporation) and Smiths Medical Inc. (ICU Medical Inc.).
Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2022 |
| Historical Period | 2017-2022 |
| Forecast Period | 2023-2028 |
| Units | US$ Million |
| Segment Coverage | Product, Type, End User, Region |
| Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | Armstrong Medical Ltd. (Eakin Healthcare Group Ltd), Atrasorb, Drägerwerk AG & Co. KGaA, General Electric Company, Intersurgical Ltd., Löwenstein Medical SE & Co. KG, Micropore Inc., Molecular Products Group plc (Filtration Group Corporation) and Smiths Medical Inc. (ICU Medical Inc.). |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global anesthesia CO2 absorbent market was valued at US$ 73.9 Million in 2022.
We expect the global anesthesia CO2 absorbent market to exhibit a CAGR of 6.3% during 2023-2028.
The rising incidences of chronic conditions, such as cardiac disorders, neurological conditions, respiratory diseases, etc., along with the growing demand for anesthesia CO2 absorbent, as they absorb exhaled gases during anesthesia administration, are primarily driving the global anesthesia CO2 absorbent market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for anesthesia CO2 absorbent.
Based on the product, the global anesthesia CO2 absorbent market can be segmented into soda lime, medisorb, dragersorb, amsorb, litholyme, and others. Currently, medisorb holds the majority of the total market share.
Based on the type, the global anesthesia CO2 absorbent market has been divided into premium and traditional, where premium currently exhibits a clear dominance in the market.
Based on the end user, the global anesthesia CO2 absorbent market can be categorized into hospitals, clinics, and others. Currently, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global anesthesia CO2 absorbent market include Armstrong Medical Ltd. (Eakin Healthcare Group Ltd), Atrasorb, Drägerwerk AG & Co. KGaA, General Electric Company, Intersurgical Ltd., Löwenstein Medical SE & Co. KG, Micropore Inc., Molecular Products Group plc (Filtration Group Corporation), and Smiths Medical Inc. (ICU Medical Inc.).
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More